Central regions | Technology & innovation

Moscow supports new COVID-19 vaccine development

7 Apr '21
The Human Stem Cells Institute (HSCI), a Russian public biotech company, and the Moscow Seed Fund, the Moscow City venture investment arm, have shaken hands on the Funds $467,000 loan to support R&D required for the official registration and market introduction of a new COVID-19 vaccine. The vaccine is being developed by an HSCI subsidiary called Betuvacs, LLC, Firrma.ru reported.

The Betuvacs-CoV-2 vaccine is reportedly nearing completion of preclinical trials and, according to the developer, has revealed good enough safety and efficacy profile; strong SARS-CoV-2 antibody formation was shown during animal model tests. Betuvacs is currently putting together phase one of clinical trials.

The money that comes from the Moscow Seed Fund will be used to finance the rest of preclinical trials and the early stage of clinical ones. HSCI has already invested $585,000 from its own coffers to back the ongoing effort.
Publish in Twitter
Write to Facebook
Google Buzz
Write to LiveJournal
Show in MM
Share MK
Find Related Content

Locations: Moscow

Tags: COVID 19 (42) / vaccine (30) / Moscow Seed Fund (20) / Human Stem Cells Institute (10) / Betuvacs CoV 2 (0) / Betuvacs (0) /

Latest News: Central regions
9 Apr '21 | Finance, business | Technology & innovation
9 Apr '21 | Technology & innovation
7 Apr '21 | Technology & innovation
7 Apr '21 | Technology & innovation

Feature stories

1 Apr '21
10 Feb '21
Scientists in St. Petersburg are working on a new...
22 Dec '20
Chemists at the Tomsk State University (TSU) in...
Search (News archive - 22499)

World of the Future, World of AI

Dsight Webinar
Marchmont Tech Solutions_ENG
Luc Jones: A Guide to Doing Business in Russia and the CIS Countries
Why Russians Don't Smile
Marchmont News

Latest News

9 Apr '21
Sberbank, Russias largest savings bank, and the...
8 Apr '21
St. Petersburg scientists have completed polymer...
7 Apr '21
The Moscow Seed Fund, the Moscow City venture...

Most read stories from last week

8 Apr '21
St. Petersburg scientists have completed polymer...
9 Apr '21
EdTech startup ProgKids signed an agreement with...
9 Apr '21
Compounds can retain their electrochemical properties...